| For: | Li Z, Zhu JF, Ouyang H. Progress on traditional Chinese medicine in improving hepatic fibrosis through inhibiting oxidative stress. World J Hepatol 2023; 15(10): 1091-1108 [PMID: 37970620 DOI: 10.4254/wjh.v15.i10.1091] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i10/1091.htm |
| Number | Citing Articles |
| 1 |
Ming Yang, Qi Ge, Jingxue Zhang, Jiayi Yao, Keping Chen. Advances in the Use of Traditional Chinese Medicine in Hepatic Fibrosis Treatment. Natural Product Communications 2025; 20(7) doi: 10.1177/1934578X251354877
|
| 2 |
Chun-Ye Zhang, Ming Yang. Anti-oxidative stress treatment and current clinical trials. World Journal of Hepatology 2024; 16(2): 294-299 doi: 10.4254/wjh.v16.i2.294
Abstract(758) |
Core Tip(844) |
Full Article(HTML)(2684)
|
Full Article (PDF)-1771K(178)
|
Full Article with Cover (PDF)-2282K(201)
|
Full Article (Word)-854K(23)
|
Full Article (XML)-60K(140)
|
Audio-135K(9)
|
Peer-Review Report-216K(136)
|
Answering Reviewers-86K(171)
|
Times Cited (5)
|
Total Visits (4457)
|
Open
|
| 3 |
Ahmed A. Mohamed, Aly A. Shoun, Rana A. El-Kadi, Sandra O. Abd El-Maseh, Shimaa A. Abass. Herbal management of TAA-induced liver toxicity: Fibrosis, cirrhosis, and hepatocellular carcinoma. Pathology - Research and Practice 2025; 273 doi: 10.1016/j.prp.2025.156141
|
| 4 |
Wuying Ou, Chunyun Li. The Effect of Danshen on Fibrosis and Iron Metabolism in a Rat Model of Hepatic Fibrosis. International Journal of Pharmacology 2026; 22(2) doi: 10.31083/IJP46622
|
| 5 |
Caiyun Sun, Binlong Chen, Yaodong Hu, Silu Wang, Ting Chen, Min Xu, Qianyuan Gong. The Therapeutic Effects of Active Components from Food-Medicine Plants on Liver Fibrosis. Journal of Inflammation Research 2026; doi: 10.2147/JIR.S573983
|
| 6 |
Aize Xie, Sarisak Soontornchai, Somchai Bovornkitti, Dewen Mao, Qinglan Shi, Jianpeng You. Knowledge, Attitude, and Practice Toward Liver Fibrosis/Cirrhosis and Traditional Chinese Medicine Treatment Among Medical Staff. Journal of Evaluation in Clinical Practice 2025; 31(1) doi: 10.1111/jep.14261
|
| 7 |
Hao Ouyang, Hui Miao, Zhen Li, Duan Wu, Si-Cheng Gao, Yao-Yao Dai, Xiao-Di Gao, Hai-Sheng Chai, Wei-Ye Hu, Jun-Feng Zhu. Yinhuang granule alleviates carbon tetrachloride-induced liver fibrosis in mice and its mechanism. World Journal of Hepatology 2024; 16(2): 264-278 doi: 10.4254/wjh.v16.i2.264
Abstract(769) |
Core Tip(664) |
Full Article(HTML)(2222)
|
Full Article (PDF)-23695K(487)
|
Full Article with Cover (PDF)-24205K(195)
|
Full Article (Word)-7208K(17)
|
Full Article (XML)-113K(167)
|
Audio-108K(6)
|
Peer-Review Report-199K(151)
|
Answering Reviewers-148K(146)
|
Times Cited (1)
|
Total Visits (4149)
|
Open
|
| 8 |
Linhua Liu, Bing Wang, Yibo Ma, Kunhui Sun, Ping Wang, Meifang Li, Junlin Dong, Meirong Qin, Mingshun Li, Chunshan Wei, Ying Tan, Jinsong He, Keying Guo, Xie-an Yu. A review of Phyllanthus urinaria L. in the treatment of liver disease: viral hepatitis, liver fibrosis/cirrhosis and hepatocellular carcinoma. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1443667
|
| 9 |
Yuanmei Bai, Feifan Liu, Shifang Luo, Yan Wan, Linao Zhang, Xue Wu, Qinghua Chen, Yuhuan Xie, Peixin Guo. Experimental study on H2O2 activation of HSC-T6 and hepatic fibrosis in cholestatic mice by "Yajieshaba". Journal of Ethnopharmacology 2024; 335 doi: 10.1016/j.jep.2024.118712
|
| 10 |
Xu Yang, Rensong Yue, LiangBin Zhao, Xiushen Huang, Qiyue Wang. Banxia Xiexin Tang attenuates high glucose-induced hepatocyte injury by activating SOD2 to scavenge ROS via PGC-1α/IGFBP1. 3 Biotech 2024; 14(9) doi: 10.1007/s13205-024-04060-0
|
| 11 |
Yang Zhang, Binchuan Wang, Lisha Liu, Xu Huang, Yu Cai, Lishang Liao, Xuefeng Min, Yingjiang Gu. The mechanistic study of quercetin in the treatment of alcoholic brain injury via the JNK/P38 MAPK signaling pathway. Apoptosis 2025; 30(7-8) doi: 10.1007/s10495-025-02125-w
|
| 12 |
Jialu Shi, Xiaoyu Zhou, Jiabin Wu, Liru Zeng, Xia Wang, Wei Li, Xiao Huang, Xiaoyu Deng, Wenhong Wang. Protective effects of Astragaloside IV on various liver diseases: From chemistry to herbal medicines (Review). International Journal of Molecular Medicine 2026; 58(3) doi: 10.3892/ijmm.2026.5920
|
| 13 |
Ioannis Tsomidis, Argyro Voumvouraki, Elias Kouroumalis. Immune Checkpoints and the Immunology of Liver Fibrosis. Livers 2025; 5(1) doi: 10.3390/livers5010005
|